Pfizer To Buy Allergan In $160 Billion Deal

    New York Pfizer Inc on Monday said it would buy Botox maker
    Allergan Plc in a deal worth $160 billion to slash its U.S. tax bill,
    rekindling a fierce political debate over the financial maneuver.
    The acquisition, which would create the world’s largest drugmaker
    and shift Pfizer’s headquarters to Ireland, would also be the biggest-ever
    instance of a U.S. company re-incorporating overseas to lower its taxes. U.S.
    President Barack Obama has called such inversion deals unpatriotic and has
    tried to crack down on the practice.
    Democratic presidential front-runner Hillary Clinton pledged
    to propose measures to prevent such deals. The merger was also slammed by her
    rival Senator Bernie Sanders as well as by Republican presidential candidate
    Donald Trump.
    “The fact that Pfizer is leaving our country with a
    tremendous loss of jobs is disgusting,” Trump said in a statement. The
    numbers of those who would be out of job is yet to be known.

    Follow Us on Facebook – @LadunLiadi; Instagram – @LadunLiadi; Twitter – @LadunLiadi; Youtube – @LadunLiadiTV for updates

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here